BridgeMD
New treatment option for Vestibular Hypofunction
Official title Optokinetic Virtual Reality Stimulation in Unilateral Vestibular Hypofunction
ClinicalTrials.gov ID: NCT06517446
What this study is testing
- What it's testing
- The study will be conducted on patients diagnosed with UVH who apply to Prof. Dr.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Diagnosed with unilateral vestibular hypofunction with VNG test,
- Being between the ages of 18-65,
- Being in the A+ class on the System Usability Scale (SCS) and having a value between 96-100 percentile
You likely can't join if
- Having bilateral vestibular hypofunction
- Having a visual impairment,
- Having a neurological disorder
- Inability to communicate
The study team makes the final eligibility decision.
Where it's taking place
- Kocaeli, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kocaeli, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.